Early Stage Biotech Customer Stories
Early stage biotech companies like EpiChem, Red X, and ADDEX Therapeutics have successfully transformed their workflows with Dotmatics by overcoming data silos, accelerating analysis, centralizing data access, and enabling scientists to save significant time—up to 50%—on data analysis to focus more on experiments.
Related
Addex Therapeutics: Creating Novel Small Molecule Drugs for Patients with CNS Diseases
Addex Therapeutics, a Geneva-based biotech developing novel oral small molecule drugs for CNS diseases like Parkinson’s and Alzheimer’s, overcame challenges of outdated data management and complex R&D workflows by implementing the Dotmatics platform, which modernized their data handling, streamlined analysis, and significantly saved scientists’ time, thereby accelerating innovation.
Faster Workflows, Better UX, Deeper Integration: Inside ELN & Data Discovery Platform 7.1
Dotmatics ELN & Data Discovery Platform 7.1 introduces a major interface and navigation overhaul, enhanced scientific functionalities for Biology and Chemicals & Materials R&D, and seamless integration capabilities, all designed to streamline workflows, improve user experience, and enable more efficient collaboration and data-driven decision-making in scientific research and administration.
Dotmatics Chemicals & Materials Science Software Demo
Dotmatics offers a comprehensive, end-to-end scientific software platform that digitizes and automates lab functions for chemicals and materials research, integrating best-in-class tools like GraphPad Prism and SnapGene to help over 2 million researchers overcome data challenges, improve decision-making, and accelerate R&D workflows.
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
About Dotmatics
Dotmatics is a science-driven company with a mission to build the world’s most powerful scientific R&D platform by uniting best-in-class software applications into a flexible, data-driven ecosystem used by over 2 million scientists worldwide, enabling collaboration, automation, and analysis to accelerate innovation and address global challenges in health, environment, and safety.
Dotmatics at Future Labs, Automation & Technology 2024
Dotmatics will exhibit and host a round table discussion titled "The Data Driven Lab: From Collection to Actionable Insights," led by VP Alister Campbell, at the Future Labs, Automation & Technology 2024 event on December 3, 2024, at the Millennium Gloucester Hotel in London, focusing on integrating data collection and analysis for real-time lab decision-making.